Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSTAR study of corticosteroids after first rhinovirus-induced wheezing in infants
2015-001077-40Phase 3Active
- Sponsor
- Turku University Hospital
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and fluticasone propionate in asthma (2 arms), sponsored by Turku University Hospital. Primary endpoints: Time to new physician-confirmed wheezy episode and Time to need for regular controller medication for asthma. Started Jun 2018; status: active.
02
Drugs
dexamethasonefluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-001077-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001077-40.